Literature DB >> 10952246

Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans.

R Kutami1, Y Nakashima, O Nakashima, K Shiota, M Kojiro.   

Abstract

BACKGROUND/AIMS: Fatty change is frequently observed in small hepatocellular carcinoma (HCC) of the early stage. However, the mechanism of fatty change and its pathomorphological features in small HCC are not yet fully understood. These issues are addressed here.
METHODS: Histological examinations were conducted on 260 HCC nodules (< or =3 cm in diameter) which were surgically obtained from 249 patients. According to the distribution pattern, fatty changes were classified into two types: 'diffuse type' when the change was found throughout the cancerous nodule; and 'focal type' when the change was localized in part of the nodule. To study the pathogenesis of fatty change in HCC in relation to angioarchitecture, the number of arterial tumor vessels and intratumoral portal tracts in 104 of the 260 nodules was counted.
RESULTS: Fatty change was found in 51 of the 260 nodules (19.6%), the frequency was highest (36.4%) in the nodules whose diameter was 1.1 to approximately 1.5 cm, and the frequency decreased with the increase in tumor diameter. Small well-differentiated HCCs were often associated with a diffuse type fatty change. With the increase in tumor diameter, moderately differentiated cancerous tissues without associated fatty change appeared, and the focal type was found more frequently. According to the angioarchitecture, in HCCs < or =1.5 cm, the number of intratumoral arteries was significantly smaller in HCCs with fatty change (p<0.05), though the number of intratumoral portal tracts was not significantly different compared with HCCs without fatty change.
CONCLUSION: These findings suggest that fatty change of small HCC is closely related to the tumor size, the histological grade and insufficient development of the arterial tumor vessels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10952246     DOI: 10.1016/s0168-8278(00)80369-4

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  47 in total

1.  Liver-specific contrast agent-enhanced magnetic resonance and ¹⁸F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: report of a case.

Authors:  Tatsuaki Sumiyoshi; Michihisa Moriguchi; Hideyuki Kanemoto; Kouiku Asakura; Keiko Sasaki; Teiichi Sugiura; Takashi Mizuno; Katsuhiko Uesaka
Journal:  Surg Today       Date:  2011-12-10       Impact factor: 2.549

2.  The essence of the Japan Radiological Society/Japanese College of Radiology Imaging Guideline.

Authors:  Yasuyuki Yamashita; Sadayuki Murayama; Masahiro Okada; Yoshiyuki Watanabe; Masako Kataoka; Yasushi Kaji; Keiko Imamura; Yasuo Takehara; Hiromitsu Hayashi; Kazuko Ohno; Kazuo Awai; Toshinori Hirai; Kazuyuki Kojima; Shuji Sakai; Naofumi Matsunaga; Takamichi Murakami; Kengo Yoshimitsu; Toshifumi Gabata; Kenji Matsuzaki; Eriko Tohno; Yasuhiro Kawahara; Takeo Nakayama; Shuichi Monzawa; Satoru Takahashi
Journal:  Jpn J Radiol       Date:  2016-01       Impact factor: 2.374

Review 3.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-09       Impact factor: 11.105

4.  Histopathology of type C liver disease for determining hepatocellular carcinoma risk factors.

Authors:  Hiroshi Matsumura; Kazushige Nirei; Hitomi Nakamura; Teruhisa Higuchi; Yasuo Arakawa; Masahiro Ogawa; Naohide Tanaka; Mitsuhiko Moriyama
Journal:  World J Gastroenterol       Date:  2013-08-14       Impact factor: 5.742

5.  Classification tool for the systematic histological assessment of hepatocellular carcinoma, macroregenerative nodules, and dysplastic nodules in cirrhotic liver.

Authors:  A Quaglia; M A Jutand; A Dhillon; A Godfrey; R Togni; P Bioulac-Sage; C Balabaud; M Winnock; A P Dhillon
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

6.  Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI.

Authors:  Yoshiki Asayama; Akihiro Nishie; Kousei Ishigami; Yasuhiro Ushijima; Yukihisa Takayama; Nobuhiro Fujita; Yuichiro Kubo; Shinichi Aishima; Ken Shirabe; Takashi Yoshiura; Hiroshi Honda
Journal:  Diagn Interv Radiol       Date:  2015 Mar-Apr       Impact factor: 2.630

7.  Isolated fat-containing pancreatic metastasis from hepatocellular carcinoma.

Authors:  Hideyuki Nishiofuku; Nagaaki Marugami; Toshihiro Tanaka; Hiroshi Anai; Shinsaku Maeda; Tetsuya Masada; Masato Takano; Akira Mitoro; Kimihiko Kichikawa
Journal:  Jpn J Radiol       Date:  2013-03-29       Impact factor: 2.374

Review 8.  Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma.

Authors:  Norihide Yoneda; Osamu Matsui; Satoshi Kobayashi; Azusa Kitao; Kazuto Kozaka; Dai Inoue; Kotaro Yoshida; Tetsuya Minami; Wataru Koda; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2019-02-02       Impact factor: 2.374

9.  CRISPR/Cas9-based Pten knock-out and Sleeping Beauty Transposon-mediated Nras knock-in induces hepatocellular carcinoma and hepatic lipid accumulation in mice.

Authors:  Mingming Gao; Dexi Liu
Journal:  Cancer Biol Ther       Date:  2017-05-17       Impact factor: 4.742

Review 10.  Multistep human hepatocarcinogenesis: correlation of imaging with pathology.

Authors:  Masatoshi Kudo
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.